These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 34133792
1. TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury. Zhou J, Hu M, He M, Wang X, Sun D, Huang Y, Cheng X, Fu J, Cai J, Ma T, Tian S, Hu Y, Hu F, Liu D, He Y, Yan L, She ZG, Zhang XJ, Ji YX, Liu H, Li H, Yang H, Zhang P. Hepatology; 2021 Oct; 74(4):2133-2153. PubMed ID: 34133792 [Abstract] [Full Text] [Related]
2. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. Liu Y, Lu T, Zhang C, Xu J, Xue Z, Busuttil RW, Xu N, Xia Q, Kupiec-Weglinski JW, Ji H. J Hepatol; 2019 Oct; 71(4):719-730. PubMed ID: 31201834 [Abstract] [Full Text] [Related]
3. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury. Konishi T, Schuster RM, Lentsch AB. Am J Physiol Gastrointest Liver Physiol; 2018 Apr 01; 314(4):G471-G482. PubMed ID: 29351389 [Abstract] [Full Text] [Related]
5. CMTM5 influences Hippo/YAP axis to promote ferroptosis in glioma through regulating WWP2-mediated LATS2 ubiquitination. Fan Y, Zou HQ. Kaohsiung J Med Sci; 2024 Oct 01; 40(10):890-902. PubMed ID: 39166861 [Abstract] [Full Text] [Related]
9. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner. Kemppainen K, Wentus N, Lassila T, Laiho A, Törnquist K. Cell Signal; 2016 Dec 01; 28(12):1894-1903. PubMed ID: 27634386 [Abstract] [Full Text] [Related]
10. The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation. Aylon Y, Gershoni A, Rotkopf R, Biton IE, Porat Z, Koh AP, Sun X, Lee Y, Fiel MI, Hoshida Y, Friedman SL, Johnson RL, Oren M. Genes Dev; 2016 Apr 01; 30(7):786-97. PubMed ID: 27013235 [Abstract] [Full Text] [Related]
11. Hippo (YAP)-autophagy axis protects against hepatic ischemia-reperfusion injury through JNK signaling. Zhu S, Wang X, Chen H, Zhu W, Li X, Cui R, Yi X, Chen X, Li H, Wang G. Chin Med J (Engl); 2024 Mar 20; 137(6):657-668. PubMed ID: 37232477 [Abstract] [Full Text] [Related]
16. ARRB1 ameliorates liver ischaemia/reperfusion injury via antagonizing TRAF6-mediated Lysine 6-linked polyubiquitination of ASK1 in hepatocytes. Xu X, Zhang Z, Lu Y, Sun Q, Liu Y, Liu Q, Tian W, Yin Y, Yu H, Sun B. J Cell Mol Med; 2020 Jul 30; 24(14):7814-7828. PubMed ID: 32445435 [Abstract] [Full Text] [Related]
17. Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury. Hu J, Zhu XH, Zhang XJ, Wang PX, Zhang R, Zhang P, Zhao GN, Gao L, Zhang XF, Tian S, Li H. J Hepatol; 2016 Jan 30; 64(1):146-59. PubMed ID: 26334576 [Abstract] [Full Text] [Related]
18. TNIP3 protects against pathological cardiac hypertrophy by stabilizing STAT1. Shi H, Yu Y, Li D, Zhu K, Cheng X, Ma T, Tao Z, Hong Y, Liu Z, Zhou S, Zhang J, Chen Y, Zhang XJ, Zhang P, Li H. Cell Death Dis; 2024 Jun 26; 15(6):450. PubMed ID: 38926347 [Abstract] [Full Text] [Related]